The latest text of the WHO's pandemic treaty stays mostly unchanged in terms of intellectual property (IP) restrictions, despite skepticism from the pharmaceutical industry.
![](https://assets.euromoneydigital.com/dims4/default/4da8cf0/2147483647/strip/true/crop/6000x3375+0+313/resize/1200x675!/quality/90/?url=http%3A%2F%2Feuromoney-brightspot.s3.amazonaws.com%2Fe2%2F2c%2Fc15b67704353be586ce3a4d39d22%2Fadobestock-413241271-editorial-use-only.jpeg)
https://www.managingip.com/article/2by6m9h70y9sqpyvikagw/who-text-swerves-hard-ip-restrictions-in-future-pandemics
![](https://assets.euromoneydigital.com/dims4/default/4da8cf0/2147483647/strip/true/crop/6000x3375+0+313/resize/1200x675!/quality/90/?url=http%3A%2F%2Feuromoney-brightspot.s3.amazonaws.com%2Fe2%2F2c%2Fc15b67704353be586ce3a4d39d22%2Fadobestock-413241271-editorial-use-only.jpeg)
https://www.managingip.com/article/2by6m9h70y9sqpyvikagw/who-text-swerves-hard-ip-restrictions-in-future-pandemics
Tags:
Notizie Brevi